| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gabor G Kovacs, Stefan Klöppel, Ingeborg Fischer, Suzanne Dorner, Elisabeth Lindeck-Pozza, Peter Birner, Ingolf C Bötefür, Peter Pilz, Benedikt Volk, Herbert Budk. Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders. Neuroreport. vol 14. issue 1. 2003-04-25. PMID:12544834. |
to evaluate the involvement of serotonergic raphe nuclei, we compared the percentage of neurons synthesizing serotonin in the nucleus centralis superior (ncs), raphe obscurus and pallidus (nrop) in alzheimer's disease (ad), progressive supranuclear palsy (psp), parkinson's disease (pd), multiple system atrophy (msa), and control brains. |
2003-04-25 |
2023-08-12 |
human |
| Osamu Yokota, Seishi Terada, Hideki Ishizu, Kuniaki Tsuchiya, Yoshihiro Kitamura, Kenji Ikeda, Kenji Uéda, Shigetoshi Kurod. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC). Acta neuropathologica. vol 104. issue 4. 2002-12-27. PMID:12200618. |
recently, accumulation of alpha-synuclein (alphas), the precursor of the non-beta amyloid component (nac) of alzheimer's disease, has been shown in diverse neurodegenerative disorders, including parkinson's disease, dementia with lewy bodies, alzheimer's disease, multiple system atrophy and parkinsonism-dementia complex of guam. |
2002-12-27 |
2023-08-12 |
Not clear |
| Gabor G Kovacs, Pietro Zerbi, Till Voigtländer, Michaela Strohschneider, Gianriccardo Trabattoni, Johannes A Hainfellner, Herbert Budk. The prion protein in human neurodegenerative disorders. Neuroscience letters. vol 329. issue 3. 2002-10-28. PMID:12183028. |
we evaluate cellular prion protein (prp(c)) immunoreactivity (ir) in alzheimer's, parkinson's, diffuse lewy body, and motor neuron diseases (mnd), progressive supranuclear palsy, and multiple system atrophy. |
2002-10-28 |
2023-08-12 |
human |
| Guangyu Gu, Patricio E Reyes, Gregory T Golden, Randall L Woltjer, Christine Hulette, Thomas J Montine, Jing Zhan. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders. Journal of neuropathology and experimental neurology. vol 61. issue 7. 2002-08-07. PMID:12125742. |
this study employed a well-established technique, long-extension polymerase chain reaction (lx-pcr), to detect the multiple mtdna deletions/rearrangements in the sn of patients with pd, multiple system atrophy (msa), dementia with lewy bodies (dlb), alzheimer disease (ad), and age-matched controls. |
2002-08-07 |
2023-08-12 |
Not clear |
| G Ransmayr, G K Wenning, K Seppi, K Jellinger, W Poew. [Dementia with Lewy bodies]. Der Nervenarzt. vol 71. issue 12. 2001-03-01. PMID:11139988. |
the differential diagnoses of dlb are dementia of the alzheimer type, parkinson's disease, subcortical arteriosclerotic encephalopathy, progressive supranuclear palsy, multiple system atrophy, and rarely creutzfeldt-jakob disease. |
2001-03-01 |
2023-08-12 |
Not clear |
| M A Kuiper, T Teerlink, J J Visser, P L Bergmans, P Scheltens, E C Wolter. L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients. Journal of neural transmission (Vienna, Austria : 1996). vol 107. issue 2. 2000-09-21. PMID:10847559. |
alterations in neuronal nitric oxide (no) production may play a role in the pathophysiology of parkinson's disease (pd) alzheimer's disease (ad), and multiple system atrophy (msa). |
2000-09-21 |
2023-08-12 |
human |
| J E Duda, U Shah, S E Arnold, V M Lee, J Q Trojanowsk. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Experimental neurology. vol 160. issue 2. 2000-01-14. PMID:10619569. |
although the precise function of these proteins remains unknown, alpha-synuclein has been implicated in synaptic plasticity associated with avian song learning as well as in the pathogenesis of parkinson's disease (pd), dementia with lbs (dlb), some forms of alzheimer's disease (ad), and multiple system atrophy (msa). |
2000-01-14 |
2023-08-12 |
human |
| D F Clayton, J M Georg. Synucleins in synaptic plasticity and neurodegenerative disorders. Journal of neuroscience research. vol 58. issue 1. 1999-11-04. PMID:10491577. |
alpha synuclein also contributes to the intracellular inclusions of multiple system atrophy, and a fragment has been found in senile plaques in alzheimer's disease. |
1999-11-04 |
2023-08-12 |
Not clear |
| K Arima, K Uéda, N Sunohara, K Arakawa, S Hirai, M Nakamura, H Tonozuka-Uehara, M Kawa. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta neuropathologica. vol 96. issue 5. 1999-01-22. PMID:9829806. |
we examined neuronal cytoplasmic inclusions (ncis) and oligodendrocytic glial cytoplasmic inclusions (gcis) in the pontine nuclei in multiple system atrophy (msa) using antibodies against the non-amyloid beta component of alzheimer's disease amyloid precursor protein (nacp/alpha-synuclein). |
1999-01-22 |
2023-08-12 |
Not clear |
| S M de la Monte, Y K Sohn, N Ganju, J R Wand. P53- and CD95-associated apoptosis in neurodegenerative diseases. Laboratory investigation; a journal of technical methods and pathology. vol 78. issue 4. 1998-05-07. PMID:9564885. |
to determine whether apoptosis in other neurodegenerative diseases is mediated by similar mechanisms, p53 and cd95 expression were examined in postmortem central nervous system tissues from patients with diffuse lewy body disease (dlbd), pick's disease (pkd), progressive supranuclear palsy (psp), multiple system atrophy (msa), parkinson's disease (pd), amyotrophic lateral sclerosis (als), and down's syndrome plus alzheimer's disease (dn+ad). |
1998-05-07 |
2023-08-12 |
Not clear |
| N J Cairns, P F Atkinson, D P Hanger, B H Anderton, S E Daniel, P L Lanto. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neuroscience letters. vol 230. issue 1. 1997-09-24. PMID:9259461. |
tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in alzheimer's disease. |
1997-09-24 |
2023-08-12 |
Not clear |
| M A Kuiper, G J van Kamp, P L Bergmans, P Scheltens, E C Wolter. Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section. vol 6. issue 2. 1994-04-06. PMID:8117411. |
we measured serum alpha 1-antichymotrypsin (act) levels in patients with alzheimer's disease (ad), parkinson's disease (pd), multiple system atrophy (msa) and age-matched controls to evaluate whether serum act levels in ad patients were elevated and whether act levels in pd patients with dementia differed from those in pd or ad. |
1994-04-06 |
2023-08-12 |
Not clear |
| E Martignoni, F Blandini, F Petraglia, C Pacchetti, G Bono, G Napp. Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type. Journal of neural transmission. Parkinson's disease and dementia section. vol 4. issue 3. 1992-08-19. PMID:1320891. |
cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide y levels in parkinson's disease, multiple system atrophy and dementia of the alzheimer type. |
1992-08-19 |
2023-08-11 |
Not clear |
| E Martignoni, F Blandini, F Petraglia, C Pacchetti, G Bono, G Napp. Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type. Journal of neural transmission. Parkinson's disease and dementia section. vol 4. issue 3. 1992-08-19. PMID:1320891. |
in parkinson's disease (pd), as well as in multiple system atrophy (msa), a central noradrenergic deficit has been demonstrated, and in the dementia of alzheimer type (dat) an impaired noradrenergic transmission has been postulated. |
1992-08-19 |
2023-08-11 |
Not clear |
| A J Hughes, S E Daniel, L Kilford, A J Lee. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Journal of neurology, neurosurgery, and psychiatry. vol 55. issue 3. 1992-05-20. PMID:1564476. |
in 24 cases without lewy bodies, diagnoses included progressive supranuclear palsy, multiple system atrophy, alzheimer's disease, alzheimer-type pathology, and basal ganglia vascular disease. |
1992-05-20 |
2023-08-11 |
Not clear |
| T W Robbins, M James, K W Lange, A M Owen, N P Quinn, C D Marsde. Cognitive performance in multiple system atrophy. Brain : a journal of neurology. vol 115 Pt 1. 1992-05-14. PMID:1559159. |
the cognitive performance of a group of patients with multiple system atrophy (msa) of striato-nigral predominance was compared with that of age and iq matched control subjects, using three tests sensitive to frontal lobe dysfunction and a battery sensitive to memory and learning deficits in parkinson's disease and dementia of the alzheimer type. |
1992-05-14 |
2023-08-11 |
human |